51 |
Baxter Healthcare Corporation et al v. Agila Specialties Private Limited et al |
1:14-cv-00190 |
N.D.W.Va. |
|
|
|
|
52 |
Fresenius Kabi USA, LLC v. Mylan Laboratories Limited et al |
1:14-cv-00205 |
N.D.W.Va. |
|
|
|
|
53 |
Helsinn Healthcare SA et al v. Mylan Institutional LLC |
1:14-cv-00709 |
D.Del. |
|
|
|
|
54 |
Helsinn Healthcare SA et al v. Mylan Institutional LLC |
1:14-cv-00709 |
D.Del. |
|
|
|
|
55 |
Gilead Sciences, Inc. et al v. Mylan Inc. et al |
1:14-cv-03928 |
S.D.N.Y. |
|
- 8 Product company
- 6 University/Government/Non-profit
|
|
|
56 |
Gilead Sciences, Inc. et al v. Mylan Inc. et al |
1:14-cv-03928 |
S.D.N.Y. |
|
- 8 Product company
- 6 University/Government/Non-profit
|
|
|
57 |
OTSUKA PHARMACEUTICAL CO., LTD. v. MYLAN INC. et al |
1:14-cv-04508 |
D.N.J. |
|
|
|
|
58 |
Janssen Biotech, Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:15-cv-00130 |
N.D.W.Va. |
|
|
|
|
59 |
Janssen Biotech, Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:15-cv-00130 |
N.D.W.Va. |
|
|
|
|
60 |
Janssen Biotech, Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:15-cv-00130 |
N.D.W.Va. |
|
|
|
|
61 |
Boehringer Ingelheim Pharmaceuticals, Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:15-cv-00145 |
N.D.W.Va. |
|
|
|
|
62 |
Boehringer Ingelheim Pharmaceuticals, Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:15-cv-00145 |
N.D.W.Va. |
|
|
|
|
63 |
Boehringer Ingelheim Pharmaceuticals, Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:15-cv-00145 |
N.D.W.Va. |
|
|
|
|
64 |
Boehringer Ingelheim Pharmaceuticals, Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:15-cv-00145 |
N.D.W.Va. |
|
|
|
|
65 |
GILEAD SCIENCES, INC. et al v. Mylan Inc. et al |
1:15-cv-00149 |
N.D.W.Va. |
|
- 8 Product company
- 6 University/Government/Non-profit
|
|
|
66 |
GILEAD SCIENCES, INC. et al v. Mylan Inc. et al |
1:15-cv-00149 |
N.D.W.Va. |
|
- 8 Product company
- 6 University/Government/Non-profit
|
|
|
67 |
Teva Pharmaceuticals USA, Inc. et al v. Doctor Reddy's Laboratories Ltd. et al |
1:15-cv-00306 |
D.Del. |
|
- 2 University heritage or tie
- 8 Product company
|
|
|
68 |
Teva Pharmaceuticals USA, Inc. et al v. Doctor Reddy's Laboratories Ltd. et al |
1:15-cv-00306 |
D.Del. |
|
- 2 University heritage or tie
- 8 Product company
|
|
|
69 |
Teva Pharmaceuticals USA, Inc. et al v. Doctor Reddy's Laboratories Ltd. et al |
1:15-cv-00306 |
D.Del. |
|
- 2 University heritage or tie
- 8 Product company
|
|
|
70 |
Teva Pharmaceuticals USA, Inc. et al v. Doctor Reddy's Laboratories Ltd. et al |
1:15-cv-00306 |
D.Del. |
|
- 2 University heritage or tie
- 8 Product company
|
|
|
71 |
AstraZeneca LP et al v. Mylan Pharmaceuticals Inc. |
1:15-cv-00999 |
D.Del. |
|
|
|
|
72 |
AstraZeneca LP et al v. Mylan Pharmaceuticals Inc. |
1:15-cv-00999 |
D.Del. |
|
|
|
|
73 |
AstraZeneca LP et al v. Mylan Pharmaceuticals Inc. |
1:15-cv-00999 |
D.Del. |
|
|
|
|
74 |
AstraZeneca LP et al v. Mylan Pharmaceuticals Inc. |
1:15-cv-00999 |
D.Del. |
|
|
|
|
75 |
ABBVIE INC. et al v. MYLAN PHARMACEUTICALS INC. et al |
1:15-cv-01402 |
N.D.Ill. |
|
|
|
|
76 |
ABBVIE INC. et al v. MYLAN PHARMACEUTICALS INC. et al |
1:15-cv-01402 |
N.D.Ill. |
|
|
|
|
77 |
ABBVIE INC. et al v. MYLAN PHARMACEUTICALS INC. et al |
1:15-cv-01402 |
N.D.Ill. |
|
|
|
|
78 |
ASTRAZENECA PHARMACEUTICALS LP et al v. MYLAN PHARMACEUTICALS INC. et al |
1:15-cv-07009 |
D.N.J. |
|
|
|
|
79 |
ASTRAZENECA PHARMACEUTICALS LP et al v. MYLAN PHARMACEUTICALS INC. et al |
1:15-cv-07009 |
D.N.J. |
|
|
|
|
80 |
ASTRAZENECA PHARMACEUTICALS LP et al v. MYLAN PHARMACEUTICALS INC. et al |
1:15-cv-07009 |
D.N.J. |
|
|
|
|
81 |
Valeant Pharmaceuticals North America LLC et al v. Mylan Pharmaceuticals Inc. et al |
1:18-cv-00184 |
N.D.W.Va. |
|
|
|
|
82 |
Valeant Pharmaceuticals North America LLC et al v. Mylan Pharmaceuticals Inc. et al |
1:18-cv-00184 |
N.D.W.Va. |
|
|
|
|
83 |
Valeant Pharmaceuticals North America LLC et al v. Mylan Pharmaceuticals Inc. et al |
1:18-cv-00184 |
N.D.W.Va. |
|
|
|
|
84 |
Valeant Pharmaceuticals North America LLC et al v. Mylan Pharmaceuticals Inc. et al |
1:18-cv-00184 |
N.D.W.Va. |
|
|
|
|
85 |
Anacor Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. et al |
1:18-cv-00202 |
N.D.W.Va. |
|
|
|
|
86 |
Anacor Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. et al |
1:18-cv-01699 |
D.Del. |
|
|
|
|
87 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:20-cv-00090 |
N.D.W.Va. |
|
|
|
|
88 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:20-cv-00090 |
N.D.W.Va. |
|
|
|
|
89 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:20-cv-00090 |
N.D.W.Va. |
|
|
|
|
90 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:20-cv-00090 |
N.D.W.Va. |
|
|
|
|
91 |
Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. et al |
1:20-md-00445 |
D.Del. |
|
|
|
|
92 |
DAIICHI SANKYO COMPANY, LIMITED et al v. MATRIX LABORATORIES, LTD. et al |
2:08-cv-02752 |
D.N.J. |
|
|
|
|
93 |
DAIICHI SANKYO COMPANY, LIMITED et al v. MATRIX LABORATORIES, LTD. et al |
2:08-cv-02752 |
D.N.J. |
|
|
|
|
94 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. IMPAX LABORATORIES, INC. et al |
2:08-cv-06304 |
D.N.J. |
|
|
|
|
95 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. IMPAX LABORATORIES, INC. et al |
2:08-cv-06304 |
D.N.J. |
|
|
|
|
96 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. IMPAX LABORATORIES, INC. et al |
2:08-cv-06304 |
D.N.J. |
|
|
|
|
97 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. IMPAX LABORATORIES, INC. et al |
2:08-cv-06304 |
D.N.J. |
|
|
|
|
98 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. IMPAX LABORATORIES, INC. et al |
2:08-cv-06304 |
D.N.J. |
|
|
|
|
99 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. MYLAN PHARMACEUTICALS INC. et al |
2:09-cv-02073 |
D.N.J. |
|
|
|
|
100 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. MYLAN PHARMACEUTICALS INC. et al |
2:09-cv-02073 |
D.N.J. |
|
|
|
|